423 related articles for article (PubMed ID: 18262332)
1. Re: Maurizio A. Brausi, Mirko Gavioli, Giuseppe De Luca et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 2007;52:1414-20.
Simone G; Papalia R; Gallucci M
Eur Urol; 2008 Aug; 54(2):467; author reply 468. PubMed ID: 18262332
[No Abstract] [Full Text] [Related]
2. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment on: Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
Cagiannos I
Eur Urol; 2007 Nov; 52(5):1419-20. PubMed ID: 17507149
[No Abstract] [Full Text] [Related]
4. Re: Marco Roscigno, Cesare Cozzarini, Roberto Bertini, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 2008;53:794-802.
Chung SD; Yu HJ; Chueh SC
Eur Urol; 2008 Oct; 54(4):953-4. PubMed ID: 18508191
[No Abstract] [Full Text] [Related]
5. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
[TBL] [Abstract][Full Text] [Related]
6. [Long-term results of surgical treatment for renal pelvic and ureteral tumors].
Yokoyama M; Kano M; Sakai M; Oda H; Inoue K; Kitahara K; Kanemura M; Osada M
Hinyokika Kiyo; 1995 Oct; 41(10):761-6. PubMed ID: 8533670
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: a critical appraisal.
McNeill A; Oakley N; Tolley DA; Gill IS
BJU Int; 2004 Aug; 94(3):259-63. PubMed ID: 15291848
[No Abstract] [Full Text] [Related]
8. Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract.
Cummings KB
Urol Clin North Am; 1980 Oct; 7(3):569-78. PubMed ID: 7456169
[TBL] [Abstract][Full Text] [Related]
9. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
[TBL] [Abstract][Full Text] [Related]
10. Editorial comment.
Weiss RE
Urology; 2010 Feb; 75(2):333. PubMed ID: 20152483
[No Abstract] [Full Text] [Related]
11. Editorial comment.
Shayegan B
Urology; 2010 Feb; 75(2):332-3. PubMed ID: 20152482
[No Abstract] [Full Text] [Related]
12. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.
Childs MA; Wood CG; Spiess PE; Debiane LG; Hernandez M; Matin SF; Millikan RE; Siefker-Radtkie A; Scott SM; Pisters LL
Can J Urol; 2010 Jun; 17(3):5184-9. PubMed ID: 20566011
[TBL] [Abstract][Full Text] [Related]
13. Editorial comment on: The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
Dalbagni G
Eur Urol; 2009 Sep; 56(3):519. PubMed ID: 19559519
[No Abstract] [Full Text] [Related]
14. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
Patel HR
Eur Urol; 2009 Jun; 55(6):1407. PubMed ID: 19299074
[No Abstract] [Full Text] [Related]
16. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
Touijer K
Eur Urol; 2009 Jun; 55(6):1409. PubMed ID: 19299068
[No Abstract] [Full Text] [Related]
17. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
Autorino R; Falsaperla M
Eur Urol; 2009 Jun; 55(6):1408. PubMed ID: 19299070
[No Abstract] [Full Text] [Related]
18. Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.
Milojevic B; Djokic M; Sipetic-Grujicic S; Milenkovic-Petronic D; Vuksanovic A; Bumbasirevic U; Vukovic I; Dragicevic D; Tulic C
BJU Int; 2012 Apr; 109(7):1037-42. PubMed ID: 21883837
[TBL] [Abstract][Full Text] [Related]
19. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
[TBL] [Abstract][Full Text] [Related]
20. Editorial comment.
Russo P
Urology; 2009 Nov; 74(5):1075-6; author reply 1076-7. PubMed ID: 19883827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
